Related references
Note: Only part of the references are listed.New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer
Michelle E. Melisko et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2009)
Measles virus as an oncolytic vector platform
Boris Blechacz et al.
CURRENT GENE THERAPY (2008)
A strategy for systemic delivery of the oncolytic herpes virus HSV1716: redirected tropism by antibody-binding sites incorporated on the virion surface as a glycoprotein D fusion protein
J. Conner et al.
GENE THERAPY (2008)
Oncolytic virotherapy as a personalized cancer vaccine
Qi-Xiang Li et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Cancer-killing viruses assist gene therapies
Vicki Brower
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Immunotherapeutic potential of oncolytic virotherapy
Robin J. Prestwich et al.
LANCET ONCOLOGY (2008)
Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer
Jeremy B. Burton et al.
NATURE MEDICINE (2008)
Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded
Roberto Cattaneo et al.
NATURE REVIEWS MICROBIOLOGY (2008)
Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas
Anna Kruschinski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Modification of adenovirus capsid with a designed protein ligand yields a gene vector targeted to a major molecular marker of cancer
Natalya Belousova et al.
JOURNAL OF VIROLOGY (2008)
Systemic therapy of spontaneous prostate cancer in transgenic mice with oncolytic herpes simplex viruses
Susan Varghese et al.
CANCER RESEARCH (2007)
Treatment of implanted mammary tumors with recombinant vesicular stomatitis virus targeted to Her2/neu
Ira Bergman et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Separation of receptor-binding and profusogenic domains of glycoprotein D of herpes simplex virus 1 into distinct interacting proteins
Guoying Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The multipartite system that mediates entry of herpes simplex virus into the cell
Gabriella Campadelli-Fiume et al.
REVIEWS IN MEDICAL VIROLOGY (2007)
A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor
Jennifer C. C. Hu et al.
CLINICAL CANCER RESEARCH (2006)
Adjuvant therapy with trastuzumab for HER-2/neu-positive breast cancer
Ana M. Gonzalez-Angulo et al.
ONCOLOGIST (2006)
A herpes simplex virus recombinant that exhibits a single-chain antibody to HER2/neu enters cells through the mammary tumor receptor, independently of the gD receptors
Laura Menotti et al.
JOURNAL OF VIROLOGY (2006)
Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer
Rita Nahta et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Construction and properties of a herpes simplex virus 1 designed to enter cells solely via the IL-13α2 receptor
GY Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Different receptors binding to distinct interfaces on herpes simplex virus gD can trigger events leading to cell fusion and viral entry
PG Spear et al.
VIROLOGY (2006)
Structure of unliganded HSV gD reveals a mechanism for receptor-mediated activation of virus entry
C Krummenacher et al.
EMBO JOURNAL (2005)
Herceptin-induced inhibition of ErbB2 signaling involves reduced phosphorylation of Akt but not endocytic down-regulation of ErbB2
KE Longva et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
ERBB receptors and cancer: The complexity of targeted inhibitors
NE Hynes et al.
NATURE REVIEWS CANCER (2005)
Oncolytic herpes simplex virus vector therapy of breast cancer in C3(1)/SV40 T-antigen transgenic mice
RB Liu et al.
CANCER RESEARCH (2005)
Rescue and propagation of fully retargeted oncolytic measles viruses
T Nakamura et al.
NATURE BIOTECHNOLOGY (2005)
Mutations in herpes simplex virus glycoprotein D that prevent cell entry via nectins and alter cell tropism
S Manoj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Effective intravenous therapy of murine pulmonary metastases with an oncolytic herpes virus expressing interleukin 12
RJ Wong et al.
CLINICAL CANCER RESEARCH (2004)
The HER-2/neu gene and protein in breast cancer 2003: Biomarker and target of therapy
JS Ross et al.
ONCOLOGIST (2003)
Engineered herpes simplex virus 1 is dependent on IL13Rα2 receptor for cell entry and independent of glycoprotein D receptor interaction
G Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
HER/erbB receptors as therapeutic targets of immunotoxins in human rhabdomyosarcoma cells
C Ricci et al.
JOURNAL OF IMMUNOTHERAPY (2002)
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial
JM Markert et al.
GENE THERAPY (2000)
Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors
JN Parker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
